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SUMMARY

Maximizing the potential of human kidney organoids for drug testing and regenerative medicine and to model
development and disease requires addressing cell immaturity, the lack of a mature collecting system, and
off-target cell types. By independently generating two kidney progenitor cell populations—metanephric
mesenchyme and ureteric bud (UB)-like cells—we could generate kidney organoids with a collecting system.
We also identify the hormones aldosterone and arginine vasopressin (AVP) as critical to promote differentiation of collecting duct cell types including both principal cells (PCs) and intercalated cells (ICs). The resulting
PCs express aquaporin-2 (AQP2) protein, which undergoes translocation to the apical membrane after vasopressin or forskolin stimulation. By single-cell RNA sequencing (scRNA-seq), we demonstrate improved
proximal tubule maturation and reduced off-target cell populations. We also show appropriate downregulation of progenitor cell types, improved modeling of tubular injury, the presence of urothelium (Uro), and the
ability of Notch pathway modulation to regulate PC:IC ratios during organoid development.

INTRODUCTION
Substantial progress has been made in the development of protocols to differentiate human pluripotent stem cells (hPSCs) into
kidney organoids. By manipulating Wingless-related integration
site (Wnt) fibroblast growth factor (FGF), and transforming
growth factor b (TGF-b) pathways, hPSCs are induced to differentiate into intermediate mesoderm and subsequently both the
metanephric mesenchyme and ureteric bud (UB), which selforganize to form nephrons containing many kidney cell types
(Freedman et al., 2015; Morizane et al., 2015; Taguchi et al.,
2014; Takasato et al., 2014; Xia et al., 2014). Modifications of
the original protocols have improved results, for example, the
use of VEGF, shear stress, or transplantation into immunodeficient mice to induce vascularization (Czerniecki et al., 2018; Homan et al., 2019; van den Berg et al., 2018). Variability in organoid
differentiation between batch and cell line is now increasingly
recognized as is the presence of off-target cell populations
(Phipson et al., 2019; Subramanian et al., 2019; Wu et al.,
2018). We have recently shown that single-cell RNA sequencing
(scRNA-seq) can reveal signaling pathways whose inhibition reduces the differentiation of off-target cells (Wu et al., 2018).
However, limitations to current kidney organoid differentiation
protocols remain. While recent genetic lineage analysis indicates
that UB derivatives are present in some kidney organoids (Howden et al., 2019), until recently other investigators have been unable to identify definitive UB lineage (Subramanian et al., 2019)

including principal cell (PC) markers such as aquaporin-2
(AQP2) as well as acid- and base-secreting intercalated cells
(ICs) (Czerniecki et al., 2018). Recently Taguchi and Nishinakamura (2017) showed that mouse embryonic stem cells (ESCs)
can be induced to form kidney organoids with a properly
branched UB-derived collecting system by inducing metanephric mesenchyme and UB separately and then recombining
them. This protocol required the concurrent addition of primary
stromal progenitors isolated from developing mouse kidney,
however, precluding its application to human kidney organoids.
Another limitation of current protocols is the relative immaturity of all kidney cell types generated, which resemble first- and
second-trimester fetal kidney rather than differentiated cell types
(Subramanian et al., 2019; Takasato et al., 2016; Wu et al., 2018).
Fetal kidney cells may not be well suited to model disease or
epithelial function.
Mae et al. (2018) reported a protocol for the induction of UB
from hPSCs. Based on that work, Tsujimoto et al. (2020) recently
reported a system for separate induction of mesodermal progenitors from hPSCs. After combination, the resulting organoids
generated glomeruli and tubules as well as collecting duct and
could become vascularized after transplantation in vivo. Here,
we establish a different protocol for the separate induction of
both metanephric mesenchyme and UB-like progenitors from
hPSCs. Combination of these progenitors results in collecting
duct-like structures that, with the addition of the hormones vasopressin and aldosterone, develop both PCs and ICs expressing
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terminal differentiation markers. Other tubular segments also exhibited enhanced maturation, including vasopressin-induced
membrane translocation of AQP2 protein and appropriate induction of injury markers in response to cisplatin. We could also
detect for the first time urothelial (Uro) cells and could shift the
ratio of PCs and ICs by modulating Notch signaling.
RESULTS
Separate Induction toward Metanephric Mesenchyme
and UB Improves Collecting Duct Branching
We primarily used the induced PSC (iPSC) line BJFF.6 for these
studies. Having previously shown by scRNA-seq that hPSCs
differentiated using the Takasato protocol to day 7 most closely
resemble posterior intermediate mesoderm (PIM), we followed
this protocol for PIM induction (Wu et al., 2018). In order to
generate anterior intermediate mesoderm (AIM) in parallel, we
made modifications to the Nishinakamura protocol (Taguchi
and Nishinakamura, 2017). We accomplished mesoderm induction with 3 days of exposure to the Wnt agonist CHIR99021
(CHIR) rather than 1.5 days, delayed addition of activin and
BMP4 until day 1, and omitted the TGF-b receptor (TGF-bR) inhibitor SB431542 entirely. We also observed improved tubulogenesis in joint culture when AIM induction included heparin
and activin at later stages (data not shown). The PIM and AIM induction schemes are shown in Figure 1A.
We monitored the expression of AIM versus PIM markers over
time by qPCR. AIM markers LHX1, EMX2, and GATA3 were
appropriately induced in AIM (Figure 1B), and PIM markers
GDNF, T, SIX2, and HOXA11 were appropriately expressed in
PIM (Figure 1C). Immunofluorescence analysis revealed strong
expression of the AIM marker GATA3 in AIM, but not PIM, and
conversely strong expression of the PIM marker HOXD11 in
PIM, but not AIM (Figures 1D and S1A). Based on this limited
panel of markers, these results suggest that we were able to
differentiate AIM-like and PIM-like progenitors.
At day 7, cells were dissociated from monolayer culture and
mixed at ratios from 3:1 to 1:3 followed by a CHIR pulse for 1
h. For the next 5 days, the combined organoids were incubated
in a cocktail including FGF9, heparin, glial-cell-line-derived neurotrophic factor (GDNF), retinoic acid, and epidermal growth factor (EGF) (Figure 1A). Organoids were left to mature in basal
medium without growth factors from day 12 to day 26, similar
to prior protocols. Both the 1:1 and 1:3 ratios (PIM:AIM) showed
some evidence of keratin 8 (CK8)-positive branched structures
at day 26; these ratios were used for further studies (Figure S1B).
Of note, AIM cultured alone for the whole protocol did not lead to
the differentiation of lotus tetragonolobus lectin (LTL)-positive
proximal tubule (Figure S1B).
Aldosterone and Vasopressin Drive Collecting Duct
Maturation
Despite the improved UB patterning with this protocol, markers
of PC differentiation such as AQP2 were undetectable (data not
shown), as has been observed in other organoid differentiation
protocols (Czerniecki et al., 2018; Subramanian et al., 2019).
Recently, important roles for the circulating hormone triiodothyronine in cell specification of human retinal organoids were re-
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ported (Eldred et al., 2018). We therefore considered whether
other circulating hormones that act specifically on PCs might
aid in cell maturation. Exposure to angiotensin-converting
enzyme inhibitors during pregnancy is associated with congenital anomalies and particularly renal tubular dysgenesis (Gubler,
2014), suggesting that the renin-angiotensin-aldosterone axis
might regulate tubulogenesis. Arginine vasopressin (AVP), also
known as antidiuretic hormone, is another circulating hormone
that regulates PC water permeability and induces AQP2 transcription (Ecelbarger et al., 1997; Nielsen et al., 1993; Pearce
et al., 2015), providing further rationale to test its role in PC
maturation.
To test the role of aldosterone and AVP in collecting duct
maturation, we compared day 12 to day 26 in basal medium
alone versus 10 nM aldosterone and 10 nM AVP. We also
included 100 nM K252a, an inhibitor of neurotrophic receptor
tyrosine kinase 2, since we have shown that this reduces offtarget neurons by 90% (Wu et al., 2018). This is a lower concentration than our original report because we observed
smaller organoids at higher concentrations in this protocol;
however, we could document that the lower dose still inhibited
off-target neuronal differentiation (Figure S2A). Inclusion of the
hormones strongly induced the expression of PC maturation
markers including AQP2, SCNN1G, and KCNJ1 as reflected
by bulk qPCR. It also upregulated IC markers (AQP6,
ATP6V1B1, and CLCNKA), a cell type not previously reported
in kidney organoids (Figure 1E). Both aldosterone and vasopressin were required for the full effect (Figure S2B). By
contrast, exposure of organoids generated in our laboratory
by the Takasato protocol to the same conditions from day 12
to day 26 did not result in the generation of PC or IC types (Figures S3A and S3B). These results suggested that aldosterone
and AVP drove maturation of both PC and IC types. We
observed qualitatively similar results in the human ESC
(hESC) line H9 (Figures S3C and S3B).
Enhanced Collecting Duct Cell Maturation
We next assessed cell type diversity by immunofluorescence
analysis. AQP2 protein could be detected on a subset of the collecting duct marker dolichos bifloris agglutinin (DBA)-positive
cells (Figure 2A). These cells were scattered within the presumptive UB lineage. We could also detect the protein product of
ATP6V1B1, the B1 subunit of the v-type proton ATPase, in a
separate subset of collecting duct cells, indicating the emergence of IC types. All other major kidney cell types could be detected as well, including proximal tubule (LTL), distal tubule
(E-cadherin and SLC12A1), podocytes (WT1 and NPHS1), endothelium (platelet endothelial cell adhesion molecule-1, CD31),
and stroma (MEIS1 and PDGFRB) (Figure 2A).
We confirmed that AQP2 was co-expressed within the
GATA3-positive collecting duct population, and we could not
detect AQP2 protein in the GATA3 population from Takasato organoids (Figure 2B). In organoids differentiated with the current
protocol, larger duct-like structures could be seen emerging
from areas of tubulogenesis, whereas such duct-like structures
were absent from Takasato organoids. By immunofluorescence
analysis, these larger ducts were GATA3 positive, contained a
scattered AQP2-positive cell population, and emerged from
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Figure 1. Separate Induction of Anterior and Posterior Intermediate Mesoderm and Effect of Aldo and Vasopressin on Collecting Duct (CD)
Maturation
(A) Outline of the Uchimura protocol. A, activin (ng/mL); Aldo, aldosterone (nM); AVP, arginine vasopressin (nM); B, BMP (ng/mL); C, CHIR (mM); E, EGF (ng/mL); F,
FGF9 (ng/mL); G, GDNF (ng/mL); H, heparin (mg/mL); K, K252a (nM); LDN, LDN193189 (nM); SB, SB431542 (mM); R, 0.1 mM retinoic acid; Y, 10 mM Y27632.
(B and C) Temporal kinetics of AIM and PIM marker gene expression during the first week of differentiation by qPCR (n = 3).
(D) Fluorescence images of AIM marker GATA3 compared with PIM marker HOXD11 during initial differentiation. Scale bars, 100 mm.
(E) Maturation of organoids between day 12 and day 26 in basal medium versus Aldo10, AVP10, and K100 reveals much greater induction of principal cell (PC) as
well as intercalated cell (IC) markers in the latter condition (qPCR; n = 3–4). *p < 0.05 and **p < 0.01.

the center of the organoid extending to proximal tubules
located on the organoid periphery (Figures S4A–S4C; Videos
S1 and S2).

To better visualize collecting duct organization, we performed
whole-mount immunofluorescence analysis on cleared organoids from both protocols stained with the proximal tubule marker
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Figure 2. Characterization of Organoid CD Development and Differentiation
(A) Fluorescence images from day 26 organoids including Aldo and vasopressin show the presence of major kidney cell types, including PCs (AQP2 and DBA) and
ICs (ATP6V1B1). Scale bars, 50 mm.
(B) Fluorescence images showing that Uchimura protocol organoids generate GATA3 and AQP2 copositive CD cells, whereas AQP2 expression is not detectable
in Takasato organoids. Scale bars, 20 mm.
(C) Comparison of CK8-positive tubule organization in Takasato versus Uchimura organoids.
(D) Whole mount showing glomeruli and proximal tubules on periphery and CD located in the central region. Scale bar, 100 mm.
(E) Whole-mount images of CK8-positive CD with SOX9-positive ureteric bud (UB) tips at periphery. Scale bar, 500 mm.

LTL and the UB marker CK8. Organoids differentiated with the
Takasato protocol showed localized proximal tubules with adjacent UB structures in a random pattern (Figure 2C). By contrast,
the current protocol was characterized by glomeruli and proximal tubules on the periphery of the organoid, with CK8-positive
collecting duct structures in the center (Figure 2D). There was a
modest degree of UB branching that could be visualized by
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whole-mount CK8 staining. Of note, UB tips selectively expressed SOX9, suggesting the existence of both SOX9+ ureteric
tip and SOX9 stalk (Figure 2E).
We next measured maturation markers in organoids generated
with our protocol compared with organoids generated in our laboratory using the Takasato protocol. Comparison of polarized
expression of basolateral Na/K/ATPase and apical LTL revealed

ll
OPEN ACCESS

Article
A

B

C

(legend on next page)

Cell Reports 33, 108514, December 15, 2020 5

ll
OPEN ACCESS

denser apical expression of LTL in proximal tubules differentiated
using the current protocol (Figure 3A). This was confirmed by scanning electron microscopy where proximal tubule from our protocol
had a higher microvillus density (Figure 3B). Consistent with this
finding, there was much higher mRNA for the proximal tubule
gene SLC34A1 in our organoids than for those generated by us
with the Takasato protocol as measured by qPCR (Figure 3C).
There was also decreased SIX2 expression, suggesting differentiation of metanephric mesenchyme. While the podocyte marker
NPHS1 was unchanged, there was increased expression of thick
ascending limb marker SLC12A1 and the distal convoluted tubule
markers SLC12A3 and CALB1 (Figure 3C). Also consistent with our
earlier observations, we could measure substantially increased
AQP2 expression and expression of IC markers SCNN1G,
ATP6V1B1, and AQP6 in organoids generated with the current
protocol compared with those generated with the Takasato protocol. Expression of stromal markers was also modestly elevated
(Figure 3C).
scRNA-Seq to Define Cell Diversity and Maturity
In order to comprehensively investigate cell diversity in organoid cell types, we performed scRNA-seq using the 10x Genomics platform. After quality control filtering, we obtained 16,939
cells from day 26 kidney organoids from our protocol and
compared them with 19,015 cells generated in parallel from
the original Takasato protocol (Takasato et al., 2016). We performed integrative analysis on both datasets using Harmony,
an algorithm that enables joint analysis of separate datasets
(Korsunsky et al., 2019). Unsupervised graph-based clustering
of the combined datasets followed by post hoc annotation of
the clusters defined a total of 13 major organoid cell types
with highly consistent expression patterns across protocols
(Figures 4A and 4D). This included one glomerular cell type expressing typical podocyte markers (PODXL and NPHS2), two
mesenchymal cell types, two tubular cell types transcriptomically resembling the fetal proximal tubule and loop of Henle
(Figure S5), one cluster expressing collecting duct markers
(GATA3 and AQP2), and seven non-renal cell types (Figures
4A and 4D). Each kidney cell type contained cells from both
protocols (indicating that technical variations were regressed
out by Harmony) but with varying proportions (suggesting that
biological differences were retained) (Figures 4B and 4C).
Although we could detect rare endothelial cells by immunofluorescence, these did not form an independent cluster from
either protocol, indicating that our adaptation of the Takasato
protocol may have differences in cell composition from what
was originally reported (Takasato et al., 2015).
Consistent with the immunofluorescence and qPCR results
(Figure 1), our modified protocol generated a greater number

Article
of cells categorized as collecting duct (8-fold more compared
with the Takasato protocol) (Figure 4C). This PC population
comprised 28% of the organoid, and 53% of these cells expressed AQP2. Our protocol also reduced the number of offtarget cells by 4.6-fold, most likely because we included BDNF
signaling pathway inhibition (Figures 4C and S2A) (Wu et al.,
2018). These results were confirmed by performing independent
clustering on each dataset (Figures 4E and 4F). We could detect
greater expression of GATA3 in cells from our protocol than from
the Takasato protocol. AQP2 expression was absent from Takasato organoids (Figures S4D–S4G).
We next quantified the degree of maturation of organoidderived PCs by comparing them with their fetal and adult counterparts (Figures S5A–S5C) (Hochane et al., 2019; Wu et al.,
2018). In order to simplify the comparison, we also selected
only PCs in which AQP2 expression was detected. Projecting
the cell source onto the clusters showed that nearly all (95.2%)
of the organoid-derived PCs clustered with fetal and not adult
PCs (Figure 4G). Dotplot visualization of selected differentially
expressed genes confirmed the fetal nature of organoid-derived
PCs (Figure 4H). We also selected a set of marker genes for PCs
based on analysis of existing adult human kidney scRNA-seq
and compared relative expression of these between PCs from
our protocol versus the Takasato protocol. This showed
increased markers of PC maturation in our protocol as well as
persistent expression of developmental markers in Takasato
protocol PCs (Figures S5D and S5E).
Our bulk mRNA analysis indicated higher expression of proximal tubule maturation markers in our protocol, so we next quantified their maturation state using the scRNA-seq datasets.
Subclustering of all proximal tubules from both protocols identified three proximal tubule subtypes whose separation was primarily driven by the degree of maturation (Figure 4I). For
example, two of the three clusters expressed cell-cycle and progenitor marker genes. More than 75% of the proximal tubule
cells from our protocol were grouped into the mature proximal
tubule cluster, whereas >65% of the Takasato protocol proximal
tubule cells were grouped in the two immature clusters (Figure 4J). In line with this finding, the current protocol proximal tubule cell expressed higher mature markers (DAB2, ALDH1,
CUBN, and LRP2), whereas the Takasato protocol proximal tubule cells strongly expressed cycling genes (MKI67, CENPF,
and HMGB2) and tubular progenitor markers (CCND1, PAX2,
and LHX1) (Figure 4K).
hPSC-Derived Kidney Organoids Contain Uro
Our protocol generated a substantial number of collecting duct
cells (28.5% of the total), so we next asked whether separate
cellular subtypes might exist within this lineage. A second

Figure 3. Assessment of Organoid Maturation
(A) LTL staining suggests that proximal tubule possesses a more developed LTL-positive brush border (*) compared with Takasato organoids (#). Scale bar, 50 mm
in low-power images and 10 mm in high-power images.
(B) Scanning electron micrographs comparing proximal tubules from Takasato and Uchimura protocols. Relatively few microvilli are visible in the Takasato
organoid (#), whereas microvillus density is higher in Uchimura protocol organoids (*). Representative images from n = 3 biologic replicates. Scale bar, 5 mm in top
images and 1 mm in bottom images.
(C) Comparison of the average expression of marker genes and developmental genes between organoid protocols (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001.
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round of clustering on the collecting duct cluster revealed four
distinct collecting duct subtypes including UB cells, PCs, ICs,
and Uro cells (Figure 5A). Inspection of the gene expression
unique to each subcluster confirmed the identity of each cell
subtype (Figure 5B). Of note, some AQP2-positive PCs also expressed IC markers, suggesting that they may either represent
PC-IC transition cells that have been previously described
(Park et al., 2018), or alternatively, bipotential progenitor cells
(Figure 5B).
Cells within a single lineage exist at different stages of differentiation within the same organoid. Since PC and IC derive
from UB, we therefore performed pseudotime trajectory analysis on the UB, PC, and IC clusters. The pseudotime trajectory
began with UB cells and subsequently bifurcated, leading
either to PC or IC fate (Figure 5C). To identify candidate transcription factors driving PC and IC differentiation from UB,
we inferred gene expression dynamics across pseudotime. Extracting transcription factors over this trajectory revealed 51
transcription factors (TFs) that were upregulated during PC/IC
differentiation (Figures 5D and 5E; Table S1). These included
transcription factors already known to be expressed in developing collecting duct or to regulate collecting duct fate and
function such as TFCP2L1 (Werth et al., 2017), KLF6
(Fischer et al., 2001), TOX3 (Harding et al., 2011), FOXQ1
(Blomqvist et al., 2004), PAX8 (Narlis et al., 2007), and LHX1
(Kobayashi et al., 2005). To identify genes specific either to
the PC or the IC branch, we performed branch analysis using
the branched expression analysis modeling algorithm (BEAM)
in Monocle (Qiu et al., 2017). This analysis generated 493 differentially expressed genes with the majority of these present in
the IC trajectory (Table S2).
Uro cells have not been described in kidney organoids to date,
but they do arise from UB progenitors, so we better characterized this cluster to distinguish it from collecting duct (Mendelsohn, 2009). Although some of the genes expressed in this cluster are also found in distal collecting duct (UPK2 and KRT7),
others are specific to Uro (UPK1B, UPK3B, FAM46A, and
CLIC). To assign identity to the Uro cluster in an unbiased way,
we mapped the Uro transcriptomes to lower tract cell types
from the Human Cell Landscape in an unsupervised fashion
(Han et al., 2020). The only cell types the organoid cluster mapped to were ureteric epithelium (Figure 5F), providing strong evidence for our Uro annotation. We also confirmed expression of
UPK2 and KRT7 by immunofluorescence analysis. Organoid Uro
cells were copositive for GATA3 and formed relatively wide linear
structures without a discernible lumen (Figure 5G). We could not
detect UPK2 expression in organoids differentiated by the Taka-
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sato protocol (Figures 5H and 5I). These results show that Uro
cells are a genuine cell type present in our kidney organoids, indicating that kidney organoids hold potential for modeling ureteral
development.
Modeling Tubular Injury, Collecting Duct Water Channel
Translocation, and PC-IC Interconversion
Several groups have reported modest induction of apoptosis
and kidney injury markers such as HAVCR1 in response to
tubular toxins (Czerniecki et al., 2018; Higgins et al., 2018; Morizane et al., 2015; Takasato et al., 2015), and the ability to faithfully model injury and repair in kidney organoids represents a
goal for the field. Neutrophil gelatinase-associated lipocalin
(NGAL) is an early biomarker for ischemic, septic, or nephrotoxic
kidney injury that is expressed in both thick ascending limb and
collecting duct and that to our knowledge has not been detected
in kidney organoids (Paragas et al., 2011). Hepatitis A virus
cellular receptor 1 (HAVCR1) is also induced by toxic or ischemic
kidney injury specifically in the proximal tubule (Ichimura et al.,
1998). The epithelial toxicant cisplatin induced both NGAL and
HAVCR1 mRNA expression in organoids generated with our protocol (Figure 6A). We could also verify that apically located
HAVCR1 protein was induced specifically in LTL-positive proximal tubules, and NGAL protein was induced specifically in
ECAD-positive distal tubules, as expected (Figure 6B). NGAL
protein could also be detected by western blot (Figure S6A).
AVP-stimulated insertion of AQP2 into the apical membrane of
the PC represents the primary mechanism by which the kidney
regulates water balance in the body (Pearce et al., 2015). The
ability to model this process in a kidney organoid where the local
cellular and environmental cues more closely mimic the in vivo
situation may provide insights compared with in vitro PC culture
models. We subjected day 26 organoids to washout of aldosterone and AVP for 24 h, followed by stimulation with vehicle or
10 nM AVP for 3 h. AVP stimulation resulted in the translocation
of AQP2 protein from a primarily cytosolic localization to the apical membrane (Figures 6C and S6B). AQP2 insertion into the apical membrane is dependent on cAMP-dependent protein kinase
A (PKA) activation. We could also trigger translocation of cytosolic AQP2 protein to the plasma membrane in sorted DBA-positive cells by the adenylate cyclase agonist forskolin (Figure 6D).
The ratio of PCs to ICs in collecting duct is regulated during
development by Notch signaling (Jeong et al., 2009). Interconversion of these cell types can also be induced by manipulating
the Notch pathway in the adult, and cells undergoing this transition have been characterized by scRNA-seq (Park et al., 2018).
To test whether the composition of collecting duct cell types

Figure 4. Comparison of Kidney Cell Types and Differentiation State in Takasato versus Uchimura Protocols
(A) Uniform manifold approximation and projection (UMAP) co-projection of scRNA-seq data from both the Takasato and Uchimura protocols.
(B) Assignment of protocol of origin to all cells reveals that most of the off-target cell types originated from the Takasato protocol.
(C) Comparison of percentage of cells across clusters between the two protocols.
(D) Violin plot showing marker gene expression for all cell types from both protocols.
(E and F) UMAP projection of the Takasato protocol organoids alone and expression of CD markers GATA3 and AQP2.
(G and H) UMAP projection of the Uchimura protocol and expression of GATA3 and AQP2.
(I) All proximal tubule cells from both protocols co-projected and identified by protocol (top) or by unsupervised clustering of the combined dataset (bottom).
(J) The Uchimura protocol had a larger proportion of mature proximal tubule and smaller proportion of progenitor and cycling proximal tubule cells.
(K) Dotplot comparing expression of proximal tubule maturation markers and developmental markers between the two protocols.
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Figure 5. Heterogeneity of CD Cells Derived from This Protocol
(A) Four cell types were identified from subclustering analysis of the CD cells.
(B) Expression of known cell type markers in each cluster. Note that urothelial markers UPK1B and UPK2 were specifically expressed in the organoid urothelium.
(C) Pseudotime trajectory analysis revealed bifurcating differentiation trajectories of PC and IC.
(D) Differentially expressed genes across the PC and IC trajectories.
(E) Expression of transcription factor TFCP2L1 across pseudotime.
(F) Unsupervised analysis (Pearson correlation) comparing the organoid urothelial cluster to the top 20 most similar cell types from the Human Cell Landscape.
(G) Validation of urothelial marker gene expression by immunofluorescence. Scale bar, 50 mm.
(H and I) Comparison of UPK2 expression in the kidney organoids derived from Takasato and Uchimura protocols.
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Figure 6. Organoid Injury Responses, Vasopressin-Stimulated AQP2 Insertion, and Regulation of PC and IC Ratio by Notch Pathway
(A) Upregulation of injury markers HAVCR1 and NGAL after by cisplatin in Uchimura, but not Takasato, organoids measured by qPCR (n = 5). Cisplatin was
administered for 48 h from day 26 to day 28. *p < 0.05, **p < 0.01, and ***p < 0.001.
(B) Fluorescence images showing upregulation of the proximal tubule injury marker HAVCR1 in LTL-positive proximal tubule after cisplatin exposure and distal
tubule injury marker NGAL in E-cadherin-positive distal tubules. Scale bars, 50 mm.
(C) Fluorescence images from whole Uchimura organoids incubated with vehicle or 10 nM AVP for 3 h after 24 h washout. AQP2 protein translocates to the apical
surface (arrowhead) after AVP stimulation. Bar graph quantifies translocation. Scale bars, 10 mm. ***p < 0.001.
(D) Flow-sorted DBA+ cells were exposed to vehicle or forskolin (FSK). Fluorescence images reveal translocation of cytoplasmic AQP2 to the F-actin-positive
plasma membrane after FSK stimulation. Scale bar, 10 mm. *p < 0.05.
(E) Relative mRNA levels of PC markers (AQP2 and KCNJ1) and intercalated cell markers (ATP6V1B1, CLCNKA, and SLC26A4) from organoids treated with either
vehicle or 100 ng/mL Jag1. *p < 0.05, **p < 0.01, and ****p < 0.001.
(F) Fluorescence images from organoids treated with either vehicle or 100 ng/mL Jag1. Scale bars, 10 mm.
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could be manipulated during kidney organoid differentiation, we
treated organoids with vehicle or the Notch agonist Jag1. By bulk
qPCR, this manipulation increased expression of PC markers
AQP2 and KCNJ1, while reducing expression of intercalated
cell markers ATP6V1B1, CLCNKA, and SLC26A4 (Figure 6E).
We confirmed reduced protein expression of ATP6V1B1 in
Jag1-treated organoids as well (Figure 6F). Of note, similar to
the scRNA-seq data, AQP2 and ATP6V1B1 copositive cells
could be detected, suggesting the possible presence of transitional cells or bipotential progenitor cells. These studies suggest
that kidney organoids hold promise as models to study PC and
IC development and interconversion.

Our modified protocol also allowed more faithful injury responses, since cisplatin could induce both HAVCR1 and NGAL
protein in proximal and distal tubule, respectively. The emergence of urothelial cell clusters also suggests the possibility
that future protocol enhancements could result in the generation
a full collecting system, potentially including a ureter. At present,
how to ‘‘plumb in’’ differentiated organoids to ureteral tissue remains a major hurdle for the field. By contrast, we observed only
occasional endothelial cells, and this is a limitation of the current
protocol. Whether shear stress might induce the formation of a
vascular network with organoids differentiated using this protocol remains an open question (Homan et al., 2019).

DISCUSSION

STAR+METHODS

Three-dimensional (3D) kidney organoids differentiated from
PSCs recapitulate many multicellular and anatomical hallmarks
of human kidney, providing an accessible experimental platform to model human organogenesis, disease, and drug testing
(Rossi et al., 2018). Two challenges that must be overcome to
more fully realize the potential of kidney organoids include
improving cell maturation and functional assessment rather
than observational characterization. Based on the original
observation that combining separately induced mouse metanephric mesenchyme and UB recapitulates branching morphogenesis (Taguchi and Nishinakamura, 2017), and the more
recent demonstration by Tsujimoto et al. (2020), we have developed a methodology to apply this approach to hPSCs. This results in collecting duct being interconnected to more proximal
nephron segments. We also report that aldosterone and AVP
drive maturation of PCs and ICs, including the ability to model
AVP-induced AQP2 translocation and water transport. Hormone treatment did not induce collecting duct from Takasato
protocol organoids, but this may not be a generalizable result
because of lab-to-lab variations in the organoid differentiation
even from the same protocol.
The presence of collecting duct with improved maturation may
have important applications. We establish the feasibility of
studying AQP2 trafficking in human PCs, for example. While
well-characterized cell culture models for studying vasopressin-mediated AQP2 biology exist, these do not recapitulate
the 3D collecting duct environment or include adjacent ICs and
whether these factors might reveal unappreciated aspects of
this pathway is unknown (Cheung et al., 2017; Rice et al.,
2015). The emergence of ICs with this protocol also provides
an opportunity to study collecting duct plasticity. Park et al.
(2018) recently showed that PCs and ICs interconvert and that
this process is regulated by Notch signaling (Park et al., 2018).
We provide proof of principle that this process can be modeled
since Notch pathway activation increased the ratio of PCs to ICs.
Organoids have already been used to model polycystic kidney
disease (PKD) (Cruz et al., 2017; Freedman et al., 2015). In autosomal dominant PKD, cysts predominantly arise from the
collecting duct, and the only approved drug to treat PKD is tolvaptan, which inhibits the vasopressin receptor that is expressed
on PCs (Grantham et al., 1987; Torres et al., 2012). The presence
of more mature collecting duct therefore offers a chance to study
cystogenesis in the most relevant cell type.

Detailed methods are provided in the online version of this paper
and include the following:
d
d

d
d

d
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Deposited Data
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Software and Algorithms
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10x Genomics
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N/A

DoubletFinder
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Fetal human kidney scRNA-seq

Hochane et al., 2019
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Adult human kidney scRNA-seq

Wu et al., 2018
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RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Benjamin
D. Humphreys (humphreysbd@wustl.edu).
Materials Availability
This study did not generate new or unique reagents.
Data and Code Availability
The accession number for the RNA sequencing data reported in this paper is NCBI GEO: GSE131086.
The human fetal and adult kidney datasets are publicly available from GEO: GSE114530 and GSE118184.
This study did not generate code.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human iPSC or ESC Culture
All experiments utilized the BJFF6 human iPSC and H9 human ESC lines (Washington University Genome Engineering and iPSC
Core). These lines are confirmed to be karyotypically normal and maintained in 6-well plates coated with matrigel (Corning) in
Stem Flex medium (Thermo Fisher Scientific). These cells were dissociated using ReLeSR (STEMCELL Technologies), confirmed
to be mycoplasma free and maintained below passage 50.
METHOD DETAILS
PIM lineage induction from human iPSCs or ESCs
Until Day 7, MM lineage cells were induced following the Takasato protocol (Takasato et al., 2016). Briefly, pluripotent stem cells were
treated with CHIR (8 mM, Tocris Bioscience) in basal medium - APEL 2 (STEMCELL Technologies) supplemented with 5% Protein
Free Hybridoma Medium II (PFHMII, GIBCO) for 4 days, followed by FGF9 (200 ng/mL, R&D Systems) and heparin (1 mg/mL,
Sigma-Aldrich) for another 3 days.
AIM lineage induction from human iPSCs or ESCs
The differentiation started with CHIR (8 uM) treatment for one day, followed by treatment with CHIR (8 mM), Activin A (10 ng/mL, R&D
Systems), and BMP4 (1 ng/mL, R&D Systems) for two days, followed by FGF9 (200 ng/mL), heparin (1 mg/mL, Sigma-Aldrich), Activin
A (1 ng/mL), RA (100 nM, Sigma-Aldrich), and LDN193189 (100 nM, Axon Medchem) for 4 days with the exception that LDN193189
was reduced to 30 nM after two days.
Generating kidney organoids by combining AIM and PIM
At day 7, AIM and PIM lineage cells were collected and dissociated into single cell suspension using 0.25% Trypsin-EDTA (Thermo
Fisher Scientific). 0.5 3 106 cells were mixed at ratios ranging from 1:3 to 3:1 and spun down at 400 g for 3 min to form a pellet. The
pellets were transferred onto a trans-well membrane and incubated with CHIR (5 mM) for 1 hour, then cultured with FGF9 (200 ng/mL),
heparin (1 mg/mL), RA (100 nM), GDNF (10 ng/mL, R&D Systems), and EGF (10 ng/mL, Thermo Fisher Scientific) for 5 days. For the
next 13 days, the organoids were cultured in basal medium supplemented with aldosterone (10 nM, Sigma-Aldrich), AVP (10 nM,
Sigma-Aldrich), and K252a (100 nM, Sigma-Aldrich) changed every other day.
Single cell RNA-seq
Organoids from Uchimura and Takasato protocols were harvested at day 26 and dissociated into single cells using TrypLE. Cells
were counted on hemocytometers (InCYTO C-chip) and partitioned into each droplet with a barcoded gel bead using the 10x Chromium instrument (10x Genomics, Pleasanton, CA). Single cell was lysed and RNAs were reverse transcribed into cDNA within each
droplet. After breaking the emulsion, cDNAs were amplified and fragmented followed by the addition of Illumina adapters using the
Chromium Single Cell 5¿ Library & Gel Bead Kit. Samples were indexed and sequenced on the S4 flow cell of NovaSeq 6000
(Illumina).
Immunofluorescence
Organoids were fixed in 4% paraformaldehyde (Electron Microscopy Services), cryoprotected in 30% sucrose solution overnight and
embedded in optimum cutting temperature (OCT) compound (Tissue Tek). Organoids were cryosectioned at 6 mm thickness and
mounted on Superfrost slides (Thermo Fisher Scientific). Sections were washed with PBS (3 times, 5 minutes each), then blocked
with 1% BSA (Sigma-Aldrich) in PBS, permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in PBS and then stained with primary
antibodies (see Key Resources Table) at 4 C overnight. Next, the sections were stained with secondary antibodies (see Key Resources Table) for 60 min at room temperature. Then, sections were stained with DAPI (40 ,60 - diamidino-2-phenylindole) and mounted
in Prolong Gold (Life Technologies). Images were obtained by confocal microscopy (Nikon C2+ Eclipse; Nikon, Melville, NY).
Whole-mount immunohistochemistry
Organoids were fixed in 4% paraformaldehyde in PBS for 60 min, washed with 0.1% Triton X-100 in PBS three times, and blocked in
PBS containing 1% BSA, 0.3% Triton X-100, and 0.2% dry skim milk (LabScientific) for 1 h twice. The tissues were incubated for two
days with primary antibodies (see Key Resources Table) on a rocking shaker at 4 C, washed with 0.3%Triton X-100 in PBS for 1 h
three times, and incubated with secondary antibodies overnight (see Key Resources Table). After immunostaining, the organoids
were cleared exactly as described (Klingberg et al., 2017). The specimens were dehydrated with 50% and 70% ethanol in H2O,
100% ethanol twice, and ethyl cinnamate. 3D fluorescence images were captured by confocal microscopy and reconstructed by
software (Nikon NIS-Elements Advanced Research).
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Scanning electron microscopy (SEM) imaging
Immediately before fixation, make a solution of 2.5% glutaraldehyde + 2% paraformaldehyde in 0.15M cacodylate buffer (final concentrations) and warm to 37þC. Gently pellet organoids in a 1.5mL eppendorf tube, remove cell media, re-suspend in warm fixative,
and return to the incubator for 5min. After 5 min, remove samples from the incubator and continue to fix for one hour at room temperature. Gently pellet, remove fixative, and rinse in 0.15M cacodylate buffer for 5 minutes. After the fixation, the images were
captured by SEM (Zeiss Merlin FE-SEM).
Real Time PCR Experiments
RNA from whole organoids was extracted using the RNeasy Mini Kit (QIAGEN) and 600 ng of total RNA was reverse transcribed with
iScript (BioRad). Quantitative polymerase chain reactions were carried out with iQ-SYBR Green supermix (BioRad) and the BioRad
CFX96 Real Time System with the C1000 Touch Thermal Cycler. Cycling conditions were 95 C for 3 minutes then 40 cycles of 95 C
for 15 s and 60 C for 1 minute, followed by one cycle of 95 C for 10 s. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as a housekeeping gene. Data was analyzed using the 2-DDct method. Primer sequences are listed in Key Resources Table.
Western blot
The organoids were washed with 1 3 PBS and lysates prepared in RIPA buffer with protease inhibitors (Roche). Protein concentration
was measured using the BCA assay (Thermo Fisher). Using 10% polyacrylamide gel, 10–20 mg of protein was separated by SDS electrophoresis and transferred to an Immobilon PVDF membrane (Millipore). Membrane was blocked with 5% milk in TBST and probed
overnight at 4 C with anti-NGAL (Abcam, #ab125075) antibody. After washing the membrane with TBST, it was incubated for 1 hour
at room temperature with HRP-conjugated secondary antibody (Dako). The membrane was developed using the ECL Detection System (GE Healthcare).
Principal Cell isolation
On day 26, the organoids were harvested and dissociated by incubation in 0.25% trypsin/EDTA for 10 min at 37 C. The single-cell
suspension was incubated with FITC-conjugated DBA (FL-1031; Vector Laboratories), and washed twice in FACS buffer. The DBA+
(FITC channel) and DBA- populations were flow-sorted (Aria II; BD Biosciences).
AQP2 trafficking assay
Isolated PCs were seeded into Matrigel coated glass chamber slides and cultured with basal medium containing 10 nM Aldosterone
and 10 nM AVP for 24 hours. After 2 hours incubation without Aldosterone or AVP, the cells were stimulated with forskolin (10 mM for
20 minutes). The cells were fixed with paraformaldehyde (4%), and AQP2 was detected using rabbit anti-AQP2 antibody and Cy3coupled secondary antirabbit antibody. Nuclei were stained with DAPI, and F-actin was labeled with FITC-phalloidin.
Quantitation of AQP2 insertion
For assessment of AQP2 insertion, we measured the distance from the apical membrane to the peak AQP2 fluorescence and divided
this by the distance from the apical membrane to the basolateral membrame. All distances were measured using ImageJ.
Jag1 experiment
Organoids from Uchimura protocol were exposed to Jag1 (100 ng/mL R&D Systems) from Day 19 to Day 26. After the Jag1 stimulation, the organoids were harvested for immunofluorescences and real time PCR.
Single cell RNA-seq data analysis
1. Pre-processing of the 10x sequencing reads
Raw reads were demultiplexed using the command ‘‘cellranger mkfastq’’ from the CellRanger toolkit (version 3.0). Read alignment,
barcode identification and UMI quantification were completed using the command ‘‘cellranger count.’’ The output gene-level UMI
count matrix for each dataset was used for downstream analysis.
2. Single cell clustering and cell type annotation
Seurat R package (v2.4)(Butler et al., 2018) was used to identify the cell types present in different organoid differentiation protocols. In
brief, we first filtered out the low quality cells if their total number of genes detected were less than 1000 or more than 4000. We also
removed the cells if their mitochondrial gene content was greater than 15%. After QC, we performed data normalization, data scaling
and dimensionality reduction using the internal functions in Seurat. Graph-based clustering was performed after running the nonlinear dimensional reduction algorithm Uniform Manifold Approximation and Projection (UMAP) (Becht et al., 2018). After applying
this clustering approach to each individual dataset, we detected and removed the doublets using the DoubletFinder package
(McGinnis et al., 2019). The ‘doublet-free’ dataset was then subject to a second round of clustering using the same clustering
approach to identify the organoid cell types for each organoid protocol. We annotated the cell clusters based on the expression
of the known cell type specific markers (after FindAllMarkers function in Seurat) and by comparing the clusters to the cell types
on the published organoid datasets (Wu et al., 2018) based on their pairwise Pearson correlation.
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3. Integrative analysis of organoid cell types from different protocols
We used Harmony (Korsunsky et al., 2019) to perform integrative analysis on the single cell transcriptomics for both Uchimura and
Takasato’s protocols. In brief, we first combined the single expression profiles for the cells from both protocols. We then performed
data normalization (‘‘NormalizeData’’ function), variable gene detection (‘‘FindVariableGenes’’ function), data scaling (ScaleData
function), and principal component analysis (‘‘RunPCA’’ function) using the default settings in Seurat. The two datasets were integrated using the ‘‘RunHarmony’’ function in Harmony package with the parameters: theta = 10, plot_convergence = TRUE, nclust =
50, max.iter.cluster = 20, and max.iter.harmony = 10. Clustering and UMAP were performed in Seurat using the ‘harmony’ data type
as the dimensional reduction type (i.e., reduction.type = ’harmony’). Cells were colored code by clusters and origins to inspect the
accuracy of the integration. Marker genes were identified from each aligned cell type using the FindAllMarkers function in Seurat.
Protocol-based variations in cell type composition were computed based on the clustering result from this integrative analysis.
4. Cell type comparison across kidney organoids, human fetal kidney and human adult kidney
To compare the collecting duct (CD) cells from kidney organoids, fetal kidney and human adult kidney, we extracted the single cell
transcriptomes for the AQP2 expressing cells from Uchimura’s kidney organoid (this study), a time course fetal kidney study (Hochane et al., 2019) and our previous published adult kidney dataset (Wu et al., 2018). We then clustered the cells from different
sources after the integrative analysis with Harmony. Cell fractions in each cluster were computed for each sample type. Mature
and immature CD markers that passed the statistical testing were selected and visualized by dot plot (DotPlot function in Seurat).
To compare the maturity of the CD cells derived from Uchimura and Takasato’s organoid protocols, we selected the cells grouped
into the same collecting duct cluster based on the integrative analysis described above. Since Uchimura’s protocol contained a lot
more collecting duct cells, this would complicate the comparison result because higher degree of cell heterogeneity tends to be
found in a larger population of cells. To address this issue, we first found the best matching CD cells between the two protocols using
a dropout weighted Pearson correlation approach (Bakken et al., 2018; Wu et al., 2019). With this approach, we ordered the cells from
Uchimura’s protocol based on the correlation score and then selected the top 594 CD cells to compare against their matched 594 CD
cells from Takasato’s protocol. Cell maturity measurement was based on their expression of the known mature and immature
markers (Drake et al., 2018; Menon et al., 2018; Wu et al., 2018) in the CD cells from each protocol. We used the similar approach
to compare the maturity of the proximal tubular cells between Uchimura and Takasato’s protocols.
5. Subclustering and pseudotime analysis of the collecting duct cells
Single cell transcriptomes for the collecting duct cells were extracted from the Uchimura dataset. Cells were reclustered by Seurat
and were annotated with the specific markers known for ureteric bud, principal cells (PC), intercalated cells (IC) and urothelium (Uro).
To identify the genes that drive the differentiation of PC and IC, Monocle (version 2) was performed on the three UB lineage cell types
(annotated with ‘UB’, ‘PC’, and ‘IC’). Differential genes were computed by an internal function in the Monocle package that finds
genes changing as a function of pseudotime. To validate the identity of the urothelium cluster in our dataset, we compared the single
cell transcriptomes of each urothelial cell to the cell types in the Human Cell Landscape (HCL) database using a R package scHCL
https://github.com/ggjlab/scHCL/. Similarity was evaluated by Pearson correlation coefficient.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Data are presented as mean ± SEM. ANOVA with post hoc Bonferroni correction was used for multiple group comparison. Student
t test was used to compare 2 different groups. Graph-Pad Prism software, version 8.0.0 (GraphPad Software Inc) was used for statistical analysis. P value < 0.05 was considered as a statistically significant difference.
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Supplemental Figure S1. HOXD11 expression in PIM vs. AIM and effect of varying
ratios of PIM:AIM on CK8-positive branched structures. Related to Figure 1. A.
mRNA for HOXD11 measured by qPCR at the indicated timepoints in AIM vs. PIM.
HOXD11 becomes undetectable in AIM by day 7. B. Whole mount immunofluorescence
images showing LTL and CK8 expresssion in Takasato organoids (left panel) or varying
ratios of PIM:AIM with the current protocol. At ratios of 1:1 and 1:3, modest CK8
branching is seen that is abset from the 3:1 ratio. Culturing of AIM alone (right panel)
results in the absence of LTL-positive proximal tubules, as expected. AIM, anterior
intermediate mesoderm; PIM, posterior intermediate mesoderm. Scale bar, 500 µm.
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Supplemental Figure S2. Effect of TRKB inhibition on off target cells and effect of
aldosterone and vasopressin alone or in combination on collecting duct marker
expression. Related to Figure 1. A. Organoids were generated and treated with
vehicle or 100 ng/L TRKB inhibitor K252a from day 12 – 26. LTL stains proximal tubule,
and CRABP1 stains off target neuronal cells. K252a reduced CRABP1+ cells by ~80%.
Representative images from n = 3 biologic replicates. Scale bar, 100 µm. B. Organoids
were generated and treated with vehicle, 10 nM aldosterone, 10 nM AVP or the
combination of aldosterone and vasopressin from days 12 – 26. mRNA levels of the
principal cell marker AQP2 or the intercalated cell marker CLCNKA were measured by
qPCR. Results are from n = 3 biologic replicates. *p<0.05.
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Supplemental Figure S3. Aldosterone and vasopressin do not induce principal cell
or intercalated cell marker expression in Takasato organoids, kidney organoids
differentiated from H9 hESCs. Related to Figure 1. A. Takasato protocol organoids
were generated and treated with vehicle or 10 nM aldosterone + 10 nM AVP from days

12 – 26. mRNA levels of the principal cell and intercalated cell markers was measured
by qPCR. The only marker that increased modestly with treatment is KCNJ1, which is
expressed in thick ascending limb and connecting segment in addition to collecting duct.
B. Immunofluorescence analysis of the same organoids revealed an absence of staining
for the principal cell protein aquaporin-2. Results are from n = 4 biologic replicates. Scale
bar, 50 µm. *p<0.05. C. Organoids were generated using the Uchimura protocol,
generating all major epithelial cell types. Scale bar, 100 µm D. Both AQP2 positive
principal cells and ATP6V1B1 positive intercalated cells were generated. Representative
images from n = 3 biologic replicates. Scale bar, 10 µm.
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Supplemental Figure S4. Large duct-like structures from new protocol and
expression of GATA3 and AQP2 between protocols. Related to Figure 2 and
Figure 4. A,B. The presence of branching larger duct structures (arrowhead) are visible
by brightfield in Uchimura organoids, but not in Takasato organoids. C. Collecting duct
(GATA3+, AQP2+) is located in the central region of the organoid with proximal tubule
(LTL+) on the periphery. Scale bar, 100 µm. D. UMAP of all cell types from Takasato
protocol organoid. E. Expression of GATA3 and AQP2 in Takasato organoid. F. UMAP
of all cell types from Uchimura organoid. G. Expression of GATA3 and AQP2 in
Uchimura organoid.
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Supplemental Figure S5. Comparison of organoid-derived cell types with fetal
kidney cell types and comparison of principal cell markers to organoid-derived
principal cells. Related to Figure 4. A. Co-projection by UMAP of human fetal kidney
from 11, 13, 16 and 18 weeks. Data is from GSE114530. B. Contribution of each
timepoint to each cluster. C. Pearson’s correlation of kidney organoid cell types to
human fetal kidney cell types. D. Expression levels for markers of mature and
developmental principal cells were queried across cell types from an adult human
kidney. scRNA-seq data is from GSE118184. E. Dotplot showing enhanced expression
of principal cell differentiation markers (GATA3, AQP2, SLC7A1, SLC9A4) in Uchimura
vs. Takasato principal cells. Takasato principal cells express higher levels of
developmental genes (HOXA10, SOX4, ARL4C, SPRY1).

A.

B.

Supplemental Figure S6. Cisplatin induces NGAL protein in kidney organoids and
example of AQP2 membrane insertion quantification. Related to Figure 6. A.
Western blot of a healthy human kidney and an acute kidney injury human kidney lysate
probed for NGAL is included as a positive control. NGAL protein is undetectable in
control organoids but upregulated by Cisplatin exposure. B. AQP2 fluorescence intensity
was quantified in between basolateral membrane anchors (arrowheads). The distance
from the apical membrane to the AQP2 peak intensity was divided by the distance from
the apical membrane to the basolateral membrane. Scale bar 10 µm.

